Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT04123457

Biorepository of Biomarkers for Optimization of Microvascular Treatment of Lymphedema

Researchers are collecting information, saliva, blood and tissue from subjects with lymphedema to store for future research.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic in Florida

Jacksonville, Florida, 32224, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult (18+ years of age)
  • Ability to provide written consent
  • Has been diagnosed with Lymphedema

Exclusion criteria

  • Under the age of 18 years old
  • Inability to provide written consent
  • Previous lymphovenous bypass or lymph node transfer surgery
  • Major changes occur to co-morbid conditions
  • Proven ICG or iodine allergy

Treatment and study plan

Primary outcomes

  1. Biospecimen Acquisition

    Time frame: 1 year

    Number of biospecimens collected

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Biorepository for Discovery and Validation of Biomarkers for Optimization of Microvascular Treatment of Lymphedema

Important dates

Study start
2019
Primary completion
2026
Study completion
2027
First posted
Oct 11, 2019
Registry last updated
Oct 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.